Shenzhen Hepalink Pharmaceutical Group News

Shenzhen Hepalink Pharmaceutical Group: Hypry's 2023 Annual General Meeting of Shareholders Legal Opinion

May 22 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 22 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: 2024 First Quarter Report

Apr 29 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: Announcement of Board Resolutions

Apr 29 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: Announcement on the renewal of accounting firms

Apr 29 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: Announcement on Additional Provisional Proposals for the 2023 Annual General Meeting of Shareholders and Supplementary Notice to the Shareholders' Meeting

Apr 29 12:00 ET

Highpree: Investor Relations Activity Record Form for April 23, 2024

Apr 23 06:11 ET

Hyperion: Announcement on holding the 2023 Annual Results Briefing

Apr 19 12:00 ET

Hyperlink: Announcement on Responding to the Inquiry Letter on the 2023 Annual Report of the Shenzhen Stock Exchange

Apr 15 12:00 ET

Hyperui: Special explanation from Ernst & Young Huaming Certified Public Accountants (Special General Partnership) on the Shenzhen Stock Exchange's “Inquiry Letter on the 2023 Annual Report of Shenzhen Haipuri Pharmaceutical Group Co., Ltd.” involving fina

Apr 15 12:00 ET

Hyperlink: Announcement of Joint Credit Assessment Co., Ltd. on terminating the credit ratings of Shenzhen Haipuri Pharmaceutical Group Co., Ltd. entities and related debts

Apr 8 03:49 ET

Hyperion: Announcement on enoxaparin sodium preparations obtaining approval for drug registration in Thailand

Apr 2 12:00 ET

Highpree: Special instructions for deducting operating income for 2023

Mar 29 12:00 ET

Hyperlink: Correction Announcement on the Annual Special Audit Report on the Occupation of Related Party Funds

Mar 29 12:00 ET

Hyperlink: Annual Special Audit Report on Related Party Capital Occupation (updated)

Mar 29 12:00 ET

Hyperion: Announcement on Using Own Funds to Purchase Wealth Management Products and Cash Management

Mar 28 12:00 ET

Hyperion: Internal Control Self-Assessment Report

Mar 28 12:00 ET

Highpree: 2023 Annual Audit Report

Mar 28 12:00 ET

Hapley: Opinions of the Supervisory Board on the “Special Explanation of the Board of Directors on Matters Involving the Unqualified Audit Opinions with Highlighted Sections in the 2023 Internal Control Audit Report”

Mar 28 12:00 ET

Hyperion: Report on the performance of supervisory duties of accounting firms by the Audit Committee of the Board of Directors in 2023

Mar 28 12:00 ET